Case Report: Retrospective pharmacist-led multidimensional assessment in a patient with late-onset first-episode mania and elevated creatine kinase

Background Late-onset first-episode mania (LOFEM) in adults aged ≥50 years is rare and frequently complicated by cerebrovascular lesions, multimorbidity, and polypharmacy, all of which increase the risk of adverse events such as rhabdomyolysis. Differentiating agitation-related from drug-induced creatine kinase (CK) elevation in this setting is clinically challenging but critical for safe pharmacotherapy. This retrospective, post-discharge pharmacist-led multidimensional assessment explored how etiological differentiation could be achieved. Case presentation A 60-year-old woman with no prior psychiatric history presented with first-episode mania. On day 2, after a single 50 mg dose of quetiapine and an intramuscular injection of diazepam on day 1 (baseline CK was not measured), her CK was 780.9 U/L and myoglobin 112.61 ng/mL, consistent with mild biochemical rhabdomyolysis without acute kidney injury. Quetiapine was continued and titrated to 200 mg/day, combined with valproate and modified electroconvulsive therapy. CK normalized by day 21 and the patient achieved full recovery of psychiatric symptoms. Conclusions A post-discharge, retrospective multidimensional pharmaceutical assessment (Naranjo scale, Beers criteria, multi-database drug-drug interaction analysis, and geriatric dose evaluation) indicated that the overall picture was most consistent with mild biochemical rhabdomyolysis related to manic agitation and dehydration/exertion, with intramuscular diazepam as an additional confounder. Quetiapine cannot be excluded as a contributor. NMS was not clinically supported.

Authors

Institutions

Publication Details

Journal
Frontiers in Psychiatry
Published
2026-11-19
DOI
https://doi.org/10.3389/fpsyt.2026.2007120
Primary Topic
Bipolar Disorder and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Case Report: Retrospective pharmacist-led multidimensional assessment in a patient with late-onset first-episode mania and elevated creatine kinase

Pan Zhang, Junlin Diao, Chunxiang Wei, Haoyang Huang
Frontiers in Psychiatry
Bipolar Disorder and Treatment
article

Case Report: Retrospective pharmacist-led multidimensional assessment in a patient with late-onset first-episode mania and elevated creatine kinase

Pan Zhang, Junlin Diao, Chunxiang Wei, Haoyang Huang
article en

Abstract

Background Late-onset first-episode mania (LOFEM) in adults aged ≥50 years is rare and frequently complicated by cerebrovascular lesions, multimorbidity, and polypharmacy, all of which increase the risk of adverse events such as rhabdomyolysis. Differentiating agitation-related from drug-induced creatine kinase (CK) elevation in this setting is clinically challenging but critical for safe pharmacotherapy. This retrospective, post-discharge pharmacist-led multidimensional assessment explored how etiological differentiation could be achieved. Case presentation A 60-year-old woman with no prior psychiatric history presented with first-episode mania. On day 2, after a single 50 mg dose of quetiapine and an intramuscular injection of diazepam on day 1 (baseline CK was not measured), her CK was 780.9 U/L and myoglobin 112.61 ng/mL, consistent with mild biochemical rhabdomyolysis without acute kidney injury. Quetiapine was continued and titrated to 200 mg/day, combined with valproate and modified electroconvulsive therapy. CK normalized by day 21 and the patient achieved full recovery of psychiatric symptoms. Conclusions A post-discharge, retrospective multidimensional pharmaceutical assessment (Naranjo scale, Beers criteria, multi-database drug-drug interaction analysis, and geriatric dose evaluation) indicated that the overall picture was most consistent with mild biochemical rhabdomyolysis related to manic agitation and dehydration/exertion, with intramuscular diazepam as an additional confounder. Quetiapine cannot be excluded as a contributor. NMS was not clinically supported.

Frontiers in PsychiatryVol. 17
Chongqing City Mental Health Center (CN)
Bipolar Disorder and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon